chr7-128972576-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_012470.4(TNPO3):āc.2280T>Cā(p.Ile760Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,613,146 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00090 ( 0 hom., cov: 31)
Exomes š: 0.0015 ( 7 hom. )
Consequence
TNPO3
NM_012470.4 synonymous
NM_012470.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.38
Genes affected
TNPO3 (HGNC:17103): (transportin 3) The protein encoded by this gene is a nuclear import receptor for serine/arginine-rich (SR) proteins such as the splicing factors SFRS1 and SFRS2. The encoded protein has also been shown to be involved in HIV-1 infection, apparently through interaction with the HIV-1 capsid protein. Several protein-coding and non-coding transcript variants have been found for this gene. [provided by RefSeq, Apr 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 7-128972576-A-G is Benign according to our data. Variant chr7-128972576-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 260263.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-128972576-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=2.38 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0009 (137/152196) while in subpopulation NFE AF= 0.0017 (116/68040). AF 95% confidence interval is 0.00145. There are 0 homozygotes in gnomad4. There are 49 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 137 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNPO3 | NM_012470.4 | c.2280T>C | p.Ile760Ile | synonymous_variant | 19/23 | ENST00000265388.10 | NP_036602.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000900 AC: 137AN: 152196Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
137
AN:
152196
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000656 AC: 164AN: 250020Hom.: 1 AF XY: 0.000762 AC XY: 103AN XY: 135146
GnomAD3 exomes
AF:
AC:
164
AN:
250020
Hom.:
AF XY:
AC XY:
103
AN XY:
135146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00146 AC: 2129AN: 1460950Hom.: 7 Cov.: 30 AF XY: 0.00141 AC XY: 1022AN XY: 726744
GnomAD4 exome
AF:
AC:
2129
AN:
1460950
Hom.:
Cov.:
30
AF XY:
AC XY:
1022
AN XY:
726744
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000900 AC: 137AN: 152196Hom.: 0 Cov.: 31 AF XY: 0.000659 AC XY: 49AN XY: 74364
GnomAD4 genome
AF:
AC:
137
AN:
152196
Hom.:
Cov.:
31
AF XY:
AC XY:
49
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 01, 2016 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | TNPO3: BP4, BS1 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 10, 2020 | - - |
Autosomal dominant limb-girdle muscular dystrophy type 1F Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2025 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at